Amanote Research

Amanote Research

    RegisterSign In

Nuclear Receptors: Emerging Drug Targets for Parasitic Diseases

Journal of Clinical Investigation - United States
doi 10.1172/jci88890
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

February 6, 2017

Authors
Zhu WangNathaniel E. SchafferSteven A. KliewerDavid J. Mangelsdorf
Publisher

American Society for Clinical Investigation


Related search

Histone Deacetylase Enzymes as Potential Drug Targets in Cancer and Parasitic Diseases

Journal of Biomedicine and Biotechnology
2006English

Adenosine Receptors as Drug Targets

Experimental Cell Research
Cell Biology
2010English

TRP Channels as Emerging Therapeutic Targets for Neurodegenerative Diseases

Frontiers in Physiology
Physiology
2020English

CB2 Receptors as New Therapeutic Targets for Liver Diseases

British Journal of Pharmacology
Pharmacology
2008English

EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design

Journal of Cancer Research Updates
2016English

Transporters as Drug Targets in Neurological Diseases

Clinical Pharmacology and Therapeutics
Pharmacology
2016English

The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Adenosine Receptors as Drug Targets for Treatment of Pulmonary Arterial Hypertension

Frontiers in Pharmacology
Pharmacology
2017English

Inhibitory G Proteins and Their Receptors: Emerging Therapeutic Targets for Obesity and Diabetes

Experimental & Molecular Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy